Is Daiichi Sankyo Gearing Up For Arbitration Against Former Ranbaxy Owners?
This article was originally published in PharmAsia News
Executive Summary
Daiichi Sankyo continues to believe previous Ranbaxy shareholders concealed information related to U.S. FDA negotiations. Sources say arbitration in Singapore could be taking shape.